• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

1995 Fiscal Year Final Research Report Summary

Oncogene and apoptosis related gene expression and radiation therapy respones of cervical cancer

Research Project

Project/Area Number 06670945
Research Category

Grant-in-Aid for General Scientific Research (C)

Allocation TypeSingle-year Grants
Research Field Radiation science
Research InstitutionNational Institute of Radiological Sciences

Principal Investigator

NAKANO Takashi  National Institute of Radiological Sciences RADIATION MEDICINE,RESEARCHER, 治療診断部, 研究員 (20211427)

Co-Investigator(Kenkyū-buntansha) OKA Kuniyuki  National Institute of Radiological Sciences RADIATION MEDICINE,RESEARCHER, 病理部, 研究員 (80094241)
Project Period (FY) 1994 – 1995
KeywordsOncogene / Apoptosis / p53 / Cervical cancer / Radiation / pMI / Growth Fraction / Immunohistochemistry
Research Abstract

Correlations between radiation response and varios biological parameters including growth fraction, cell cycle factors, oncogene, apoptosis relating gene expression of tumors and histologic features were investigated for prediction of local control probability following radiation therapy.
Immunohistochemical study was performed on 64 cervical cancer patients treated with radiation therapy.Prognosis was analyzed by c-erbB-2 oncoprotein expression (CerbB-OE), p53 protein expression, growth fraction detemined with Ki-67 immunohistochemistry (Ki-GF) and the mitotic index of proliferating cell population (pMI).
The 5-year survival rates for the Ki-GF of 33% or greater were significantly better than those below 33% (87.5% vs 44.7%, P<0.01).The difference was due to difference in recurrence rates. The 5-year survival rates for patients with pMI of 3.5% or greater were significantly lower than those below 3.5% (0% vs 81.8%, P<0.001).The difference was due also to difference in recurrence rates.C … More erbB-OE was observed on the cell membrane of cancer cells.
There was no significant correlation between p53 expression and survival.
Positivity of CerbB-OE,which was 42.4% in total, increased significantly with stage progression.Mean Ki-GF and pMI were 36% and 2.5% in total, respectively.Mean Ki-GF for CerbB(+) Patients was 26.2%, significantly lower than the 38.3% for CerbB (-) patients (P<0.01).The mean pMI for CerbB (+) patients was 3.70%, significantly higher than the 2.00% of CerbB (-) patients (P<0.05).The correlation between CerbB-OE and Ki-GF and pM1 suggests that CerbB oncoprotein may play an important role in cell proliferation status of cancer of the uterine cervix. The 5-year survival rates of CerbB (+) and CerbB (-) patients were 45.1% and 75.6%, respectively, indicating that CerbB (+) patients showed significantly poorer survival than CerbB (-) ones (P<0.01).The difference in survival was mainly due to local recurrence rather than distant metastasis.
The Ki-GF,pMI and CerbB-OE are suggested as significant predictor to local control as well as long term survival.Theses predictors are hopeful as determinants for selecting optimal therapeutic modalities. Less

  • Research Products

    (16 results)

All Other

All Publications (16 results)

  • [Publications] Nakano, T. ,: "Radiation therapy alone for adenocarcinoma of the uterine cervix." Int. J. Radiat. Oncol. Biol. Phys.32. 1333-1336 (1995)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Nakano, T: "Expression of proliferation-associated antigens in cervical carcinoma: Correlations among various indexes." Path. Res. Pract.191. 997-1003 (1995)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Nakano, T. ,: "Clinical evaluation of SCC and Ca19-9 in radiation therapy for cervical cancer. A comparative analysis between serum marker level and immunohistochemical marker expression." Cancer Detect. Prev.(in press).

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Nakano, T. ,: "Dose-volume histogram analysis of high dose rate intracavitary brachytherapy for uterine cervix cancer." Int. J. Radiat. Oncol. Biol. Physl. (in press).

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Nakano, T. ,: "Immunohistrochemical prediction of radiation response and local control in radiation therapy for cervical cancer." Clinical Immunol Imunopathol.(in press).

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 中野隆史: "Apoptosis関連Ley抗原の発現と子宮頚癌の放射線治療" 癌の臨床. 41. 1729-1737 (1995)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Oka, K., Nakano, T., Arai, T.: "Cytoplasmic p105 index is an accurate mitotic index, but is not related to prognosis in cervical carcinima." Arch.Pathol.Lab.Med.118. 506-509 (1994)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Oka, K., Nakano, T., Arai, T.: "C-erbB-2 oncoprotein expression is associated with poor prognosis in squamous cell carcinoma of the cervix." Cancer. 73. 668-671 (1994)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Nakano, T., Arai, T., Morita, S., Oka, K.: "Radiation therapy alone for adenocarcinoma of the uterine cervix." Int.J.Radiat.Oncol.Biol.Phys.32. 1333-1336 (1995)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Oka, K., Nakano, T.and Arai, T.: "Expression of proliferation-associated antigens in cervical carcinoma : Correlations among various indexes." Path.Res.Pract.191. 997-1003 (1995)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Ishikawa, A., Nakano, T., Terahara, A., Morita, S., Oka, K.: "Clinical evaluation of SCC and Ca19-9 in radiation therapy for cervical cancer.A comparative analysis between serum marker level and immunohistochemical marker expression.." Cancer Detect.Prev. (IN PRESS).

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Terahara, A., Nakano, T., Ishikawa, A., Morita, S., Tsujii, H.: "Dose-volume histogram analysis of high dose rate intracavitary brachytherapy for uterine cervix cancer.." Int.J.Radiat.Oncol.Biol.Phys. (IN PRESS).

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Nakano, T., Oka, K., Ishikawa, A., Morita, S.: "Immunohistochemical prediction ofradiation response and local control in radiation tharapy for cervical canner." Cancer Detect.Prev.(IN PRESS).

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Nakano, T., Oka, K., Hanba, K., Morita, S.: "Intratumoral administration of Sizofiran activates Langerhans cell and T-cell infiltration in cerviacl cancer." Clinical Immunol.Imunopathol.(IN PRESS).

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Oka, K., Nakano, T., Hoshi, T.: "Comparative analysis of response to radiation in cervical adenocarcinomaa and squamous cell carcinomas : MIBI and PC10 labeling indexes." Cancer. (IN PRESS).

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Nakano, T., Oka, K., Morita, S.Arai, T.: "Mn-SOD expression correlates with p53 status and local recurrence of cervical caner treated radiation therapy." Cancer Research. (IN PRESS).

    • Description
      「研究成果報告書概要(欧文)」より

URL: 

Published: 1997-03-04  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi